Mainz Biomed N.V. (MYNZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 06-2021 | 12-2020 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 8,728 | N/A | 123 |
| Receivables | 112 | N/A | 44 |
| Other current assets | 769 | 0 | 20 |
| TOTAL | $9,609 | $N/A | $186 |
| Non-Current Assets | |||
| PPE Net | 90 | N/A | 80 |
| TOTAL | $90 | $N/A | $80 |
| Total Assets | $10,041 | $N/A | $673 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 78 | N/A | 86 |
| Accounts payable and accrued liabilities | 785 | 0 | 399 |
| Accrued Expenses | 234 | N/A | 33 |
| Other current liabilities | 85 | N/A | 3 |
| TOTAL | $1,352 | $N/A | $702 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 1,940 | 0 | 2,265 |
| TOTAL | $2,328 | $N/A | $2,712 |
| Total Liabilities | $3,680 | $N/A | $3,415 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 300 | N/A | N/A |
| Common Shares | 141 | N/A | 64 |
| Retained earnings | -16,645 | N/A | -4,955 |
| Other shareholders' equity | 9,739 | 0 | 2,107 |
| TOTAL | $6,361 | $N/A | $-2,742 |
| Total Liabilities And Equity | $10,041 | $0 | $673 |